JSM Activity #291

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2002 Program page

Activity ID:  291
* Innovative Designs for Clinical Trials
Date / Time / Room Sponsor Type
8:30 AM - 10:20 AM
Room: H-West Ballroom
Biometrics Section*, Biopharmaceutical Section*, ENAR Contributed
Organizer: n/a
Chair: Nandita Biswas, GlaxoSmithKline, Inc.
Floor Discussion 9:50 AM

Issues in designing clinical trials including ethics, accelerated development, and sample size re-estimation.
  301536  By:  Karen L. Kesler 8:35 AM 08/14/2002
Non-Stop Drug Development: Statistical Methods for More Time Efficient Trials

  301897  By:  Yuko  Palesch 8:50 AM 08/14/2002
Why Not a Multi-Stage, Single-Arm Phase II Design? Application to Stroke Therapeutics

  300599  By:  Cunshan  Wang 9:05 AM 08/14/2002
Sample Size Re-estimation for Binary Data via Conditional Power

  300694  By:  Leslie A. McClure 9:20 AM 08/14/2002
Designing Clinical Trials When Treatments Favor Different Endpoints

  301763  By:  Charlie H. Goldsmith 9:35 AM 08/14/2002
Efficacy Designs when a Placebo Group is Unethical

JSM 2002

For information, contact meetings@amstat.org or phone (703) 684-1221.

If you have questions about the Continuing Education program, please contact the Education Department.

Revised March 2002